Home » Healthcare » South Africa Healthcare Contract Research Outsourcing Market

South Africa Healthcare Contract Research Outsourcing Market By Service (Clinical Trial Services, Clinical Data Management & Biometrics, Pharmacovigilance, Regulatory Services, Medical Writing, Site Management Protocol, Others); By Therapeutic Area (Oncology/Hematology, Respiratory, Central Nervous System (CNS), Cardiovascular (CV)/Metabolic, Rare Diseases, Infectious Diseases, Immunology, Others); By End-user (Pharmaceutical and Biotech Companies, Medical Devices, Government Organizations, Academic Institutes, Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
South Africa Healthcare Contract Research Outsourcing Market Size 2024	USD 670.72 million
South Africa Healthcare Contract Research Outsourcing Market, CAGR	6.09%
South Africa Healthcare Contract Research Outsourcing Market Size 2032	USD 1,076.12 million

Market Overview:

The South Africa Healthcare Contract Research Outsourcing Market is projected to grow from USD 670.72 million in 2024 to an estimated USD 1,076.12 million by 2032, with a compound annual growth rate (CAGR) of 6.09% from 2024 to 2032.

The rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders has significantly increased the demand for innovative drug development and clinical research in South Africa. As the burden of these diseases continues to grow, pharmaceutical and biotechnology companies face mounting pressure to develop effective treatment solutions. This surge in demand has led to a greater reliance on contract research organizations (CROs), which offer specialized expertise and cost-effective solutions for conducting clinical trials and research studies. The shift toward outsourcing enables companies to optimize their resources, accelerate drug discovery, and streamline regulatory processes, ultimately improving healthcare outcomes. Cost containment pressures in the healthcare sector have further fueled the market’s growth, as pharmaceutical firms seek efficient and scalable research solutions to manage rising operational expenses. CROs provide access to advanced research infrastructure and cutting-edge technologies without the need for heavy capital investments. South Africa’s evolving regulatory landscape, now more aligned with international standards, has enhanced its attractiveness as a clinical trial destination.

South Africa has established itself as the premier hub for healthcare contract research outsourcing in sub-Saharan Africa, benefiting from its advanced medical infrastructure, regulatory reforms, and strategic geographical positioning. The country’s well-developed research ecosystem, supported by government initiatives and international collaborations, has made it an attractive destination for pharmaceutical and biotechnology companies seeking high-quality clinical trial services. Johannesburg, Cape Town, and Pretoria serve as the primary research centers, housing state-of-the-art clinical facilities, world-class universities, and a skilled talent pool essential for conducting complex trials and research projects. The country’s urban regions dominate the contract research landscape due to better healthcare facilities, reliable infrastructure, and access to advanced medical technologies. However, expanding research activities into secondary cities and rural areas presents significant growth opportunities for CROs.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Insights:

The market is projected to grow from USD 670.72 million in 2024 to USD 1,076.12 million by 2032, with a CAGR of 6.09%, driven by increasing demand for clinical research outsourcing.
The rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is fueling the need for innovative drug development, increasing reliance on CROs.
Cost containment pressures in the healthcare sector are driving pharmaceutical and biotech companies to outsource research activities, reducing operational expenses and optimizing resources.
Regulatory advancements and international alignment, particularly reforms by SAHPRA, are streamlining approval processes and making South Africa an attractive destination for clinical trials.
The country benefits from a well-developed research ecosystem, with Johannesburg, Cape Town, and Pretoria serving as major research hubs due to strong infrastructure, skilled talent, and regulatory support.
Expansion of clinical trials into secondary cities and rural areas presents new opportunities for CROs, improving patient recruitment diversity and trial accessibility.
Technological advancements, including AI-driven analytics, digital health, and remote monitoring, are enhancing research efficiency, strengthening South Africa’s position as a key player in the global contract research outsourcing market.

Market Drivers:

Rising Demand for Cost-Effective Drug Development

The increasing complexity and cost of drug development have driven pharmaceutical and biotechnology companies to seek cost-efficient alternatives for clinical research. Outsourcing to contract research organizations (CROs) allows companies to reduce operational expenses, optimize resources, and focus on core competencies. For instance, studies have shown that the R&D cost for a new medicine can range from $314 million to $4.46 billion, with drug development taking between 10-15 years or even longer. South Africa has emerged as a competitive destination for outsourced research due to its well-established clinical infrastructure, lower labor costs compared to developed markets, and streamlined regulatory frameworks. These factors have encouraged international firms to invest in the region, boosting the demand for contract research services.

Expansion of Clinical Trials and Research Activities

The growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders has led to a significant rise in clinical trials across South Africa. The country’s diverse population provides an ideal setting for conducting trials with varied genetic and demographic backgrounds, making it an attractive location for global pharmaceutical firms. Additionally, increased government support for research initiatives, coupled with collaborations between academic institutions, healthcare providers, and CROs, has facilitated the expansion of clinical trials. For example, the South African Medical Research Council (SAMRC) has been actively conducting epidemiological, behavioral, basic science, and clinical research to investigate vulnerabilities to HIV, tuberculosis, and other infectious diseases, testing biomedical interventions, including vaccines and pre-exposure prophylaxis (PrEP). This trend is expected to drive continued growth in the healthcare contract research outsourcing market.

Regulatory Advancements and International Alignment

South Africa’s regulatory environment has evolved to align more closely with international standards, creating a favorable landscape for contract research outsourcing. Reforms in ethical review processes, clinical trial approvals, and data protection laws have enhanced the efficiency of research operations. For instance, the South African Health Products Regulatory Authority (SAHPRA) has streamlined approval timelines, enabling faster initiation of trials and reducing bureaucratic delays. These improvements have strengthened the country’s reputation as a reliable research destination, attracting both domestic and international stakeholders to the contract research market.

Technological Advancements and Skilled Workforce

Advancements in digital health technologies, data analytics, and artificial intelligence have transformed clinical research processes, increasing efficiency and accuracy in data management. South Africa has invested in research infrastructure, with CROs integrating electronic data capture (EDC), remote monitoring, and AI-driven analytics to enhance trial efficiency. Furthermore, the country benefits from a growing pool of skilled healthcare professionals and researchers, ensuring access to expertise in clinical trial management, biostatistics, and regulatory compliance. For instance, OnQ Research, a South African CRO, offers comprehensive services from protocol design to clinical report generation, leveraging local expertise to support diverse clinical research projects. The combination of technological innovation and a competent workforce has reinforced South Africa’s position as a key player in the global healthcare contract research outsourcing industry.

Market Trends:

Growing Adoption of Decentralized Clinical Trials

The healthcare contract research outsourcing market in South Africa is witnessing a shift towards decentralized clinical trials (DCTs), driven by advancements in digital health technologies. For instance, according to ICON plc, their Digital Platform has enabled patients to have more control and better access to personalized healthcare directly from their own devices. The adoption of remote monitoring, electronic data capture (EDC), and telemedicine has allowed for greater flexibility in clinical trial operations, reducing the need for physical site visits and improving patient participation rates. This trend has been particularly beneficial in enhancing access to clinical trials in rural and underserved areas, where traditional trial infrastructure is limited. The increasing integration of wearable health devices and AI-driven data analytics is further streamlining trial processes, enhancing data accuracy, and reducing costs for pharmaceutical companies and contract research organizations (CROs).

Expansion of Biopharmaceutical Research and Development

The biopharmaceutical sector in South Africa is growing, contributing to an increased demand for specialized contract research services. For instance, the South African Medical Research Council has collaborated with the Department of Science and Innovation and MGI to introduce precision medicine into approved medical practices. Local and international pharmaceutical companies are investing in biologic drug development, gene therapies, and personalized medicine, creating new opportunities for CROs that specialize in advanced research methodologies. The presence of well-established research institutions and collaborations with academic laboratories and biotech startups have fueled innovation in drug discovery and clinical research. Additionally, the increasing focus on biosimilar development in response to the rising demand for cost-effective treatment alternatives has strengthened the role of contract research organizations in supporting preclinical and clinical trials.

Strategic Collaborations and Outsourcing Partnerships

The market is experiencing a rise in strategic collaborations between CROs, pharmaceutical companies, and research institutions to improve the efficiency and scope of outsourced research services. Multinational firms are increasingly forming partnerships with local CROs to leverage regional expertise, navigate regulatory complexities, and access a diverse patient population for clinical trials. For instance, Syneos Health’s acquisition of Illingworth Research Group enhanced its mobile and home nursing services, enabling more flexible clinical trial designs. These collaborations enable companies to streamline drug development timelines and reduce overall research costs. Additionally, increased foreign direct investment (FDI) in South Africa’s healthcare sector has facilitated the expansion of research infrastructure and capacity-building initiatives, further positioning the country as a competitive outsourcing destination for global clinical research.

Emphasis on Regulatory Compliance and Ethical Standards

Regulatory frameworks in South Africa are undergoing continuous improvements to align with international ethical and clinical trial standards, reinforcing the country’s credibility as a hub for outsourced research. For instance, the South African Health Products Regulatory Authority (SAHPRA) has introduced measures to enhance transparency, expedite approval processes, and ensure adherence to Good Clinical Practice (GCP) guidelines. This trend has encouraged more global pharmaceutical companies to consider South Africa for clinical trials, given the reduced bureaucratic delays and improved oversight mechanisms. Additionally, the growing emphasis on data security, patient confidentiality, and ethical governance has further strengthened the market’s reputation as a reliable and compliant research destination.

Market Challenges Analysis:

Regulatory and Approval Delays

Despite improvements in regulatory processes, delays in clinical trial approvals and compliance requirements remain a challenge for the healthcare contract research outsourcing market in South Africa. The approval timeline for clinical trials can still be lengthy due to bureaucratic inefficiencies and evolving regulatory policies, which may slow down research activities. While the South African Health Products Regulatory Authority (SAHPRA) has introduced measures to expedite approvals, inconsistencies in review processes can create uncertainties for pharmaceutical companies and contract research organizations (CROs), affecting investment decisions and trial timelines.

Limited Patient Recruitment and Retention

Recruiting and retaining participants for clinical trials poses a significant challenge, particularly in rural and underrepresented populations. Although South Africa offers a diverse patient pool, factors such as low awareness of clinical trials, concerns about trial safety, and logistical barriers to accessing trial sites limit participation rates. Additionally, socioeconomic disparities and varying levels of healthcare access impact the ability of CROs to ensure diverse and representative patient recruitment. Addressing these challenges requires greater patient engagement strategies, improved public education on clinical research, and the expansion of decentralized trial models to enhance accessibility.

High Operational Costs and Infrastructure Limitations

While outsourcing clinical research to South Africa offers cost advantages compared to developed markets, high operational costs related to infrastructure development, skilled labor, and advanced research technologies pose financial constraints. The need for continuous investment in clinical trial sites, laboratory facilities, and digital research tools increases the cost burden for CROs and pharmaceutical firms. Additionally, limited access to funding and financial incentives for local research organizations can hinder the expansion of contract research capabilities.

Data Security and Compliance Risks

The increasing reliance on digital technologies, electronic health records, and remote monitoring systems has raised concerns regarding data privacy and cybersecurity risks in clinical research. Compliance with global data protection regulations, such as GDPR, requires CROs and pharmaceutical companies to implement stringent security measures, adding complexity to research operations. Ensuring data integrity, patient confidentiality, and ethical handling of research data remains a priority but also presents challenges in aligning with international compliance standards while managing operational efficiency.

Market Opportunities:

The South African healthcare contract research outsourcing market presents significant opportunities for growth, driven by the rising demand for clinical trials, expanding biopharmaceutical research, and increasing foreign investment in the region. With a genetically diverse population, South Africa offers an ideal environment for conducting clinical trials that require varied patient demographics, making it an attractive destination for global pharmaceutical and biotechnology companies. The expansion of decentralized clinical trials (DCTs) and the integration of artificial intelligence (AI) and digital health technologies provide further avenues for growth. Leveraging these innovations can improve trial efficiency, patient recruitment, and regulatory compliance, enhancing the country’s position as a preferred outsourcing hub.

The government’s commitment to strengthening healthcare research infrastructure, alongside incentives for foreign direct investment (FDI) and strategic public-private partnerships, is expected to accelerate the growth of contract research organizations (CROs). South Africa’s improving regulatory landscape, particularly through the South African Health Products Regulatory Authority (SAHPRA), has enhanced the approval process for clinical trials, reducing bureaucratic delays and encouraging more companies to invest in the region. Additionally, expanding collaborations between local research institutions and multinational pharmaceutical firms creates opportunities for specialized drug development, biosimilar research, and advanced therapeutics. As the global demand for cost-effective, high-quality outsourced research services continues to rise, South Africa is well-positioned to capitalize on these trends, further strengthening its role in the global healthcare contract research market.

Market Segmentation Analysis:

The South Africa healthcare contract research outsourcing market is segmented by service, therapeutic area, and end-user, each playing a critical role in the industry’s growth and development.

By Service, clinical trial services dominate the market, driven by increasing demand for cost-effective and efficient research solutions. The clinical data management & biometrics segment is growing due to advancements in digital technologies and AI-driven analytics. Pharmacovigilance and regulatory services are expanding as pharmaceutical firms seek compliance with evolving local and international standards. Medical writing and site management protocol services are also gaining traction, reflecting the increasing complexity of clinical trials.

By Therapeutic Area, oncology/hematology leads the market, as rising cancer prevalence drives demand for innovative treatments. Cardiovascular (CV)/metabolic and central nervous system (CNS) research are growing due to increasing cases of diabetes, neurological disorders, and lifestyle-related conditions. Infectious diseases and immunology continue to be major research areas, especially in response to global health challenges and the need for vaccine development.

By End-user, pharmaceutical and biotech companies hold the largest market share, outsourcing research to CROs for drug development and regulatory compliance. The medical devices sector is expanding, with increasing trials for innovative healthcare technologies. Government organizations and academic institutes are key players in public health research, leveraging partnerships with CROs to advance medical research and policy development.

Segmentation:

By Service

Clinical Trial Services
Clinical Data Management & Biometrics
Pharmacovigilance
Regulatory Services
Medical Writing
Site Management Protocol
Others

By Therapeutic Area

Oncology/Hematology
Respiratory
Central Nervous System (CNS)
Cardiovascular (CV)/Metabolic
Rare Diseases
Infectious Diseases
Immunology
Others

By End-user

Pharmaceutical and Biotech Companies
Medical Devices
Government Organizations
Academic Institutes
Others

Regional Analysis:

The South Africa healthcare contract research outsourcing market is geographically segmented into key metropolitan areas and emerging research hubs, with Johannesburg, Cape Town, and Pretoria leading the market. These cities collectively account for approximately 65% of the market share, driven by strong healthcare infrastructure, access to advanced medical technology, and a concentration of research institutions and pharmaceutical companies. These regions serve as primary centers for clinical trials, benefiting from a skilled workforce, regulatory support, and well-established contract research organizations (CROs). Johannesburg, the country’s economic hub, houses several leading pharmaceutical firms, research centers, and academic institutions, making it a focal point for outsourced research activities.

Cape Town holds around 20% of the market share, emerging as a growing center for biopharmaceutical research and early-phase clinical trials. The presence of world-class universities and research hospitals fosters innovation in drug development and medical research. Cape Town’s expanding role in biotechnology and biosimilar development presents new opportunities for CROs specializing in preclinical and clinical-stage research. Additionally, the city benefits from an increasing number of international collaborations and funding initiatives, further strengthening its position as a key player in the healthcare contract research outsourcing industry.

Pretoria contributes approximately 10% of the market share, serving as a regulatory and academic hub for clinical research. Home to the South African Health Products Regulatory Authority (SAHPRA) and various governmental research institutions, Pretoria plays a critical role in ensuring compliance, ethical research practices, and streamlined approval processes. The city’s regulatory expertise and proximity to policy-making bodies make it an attractive destination for companies seeking efficient trial approvals and adherence to global clinical research standards.

Beyond these core regions, secondary cities and rural areas account for the remaining 5% of the market but represent a significant growth opportunity. The expansion of decentralized clinical trials (DCTs) and government initiatives to improve healthcare infrastructure in these areas are gradually increasing research activity. The need for diverse patient populations in clinical trials, particularly for studies on infectious diseases and chronic illnesses, is driving interest in these regions. Additionally, mobile health technologies and remote monitoring solutions are making it easier to conduct trials outside of major metropolitan centers, broadening the scope of outsourced research services in South Africa.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis:

Medpace
IQVIA
Parexel International
Covance
Charles River Laboratories
PPD
Syneos Health
Thermo Fisher Scientific Inc.
Pharmalex
Avoca CRO

Competitive Analysis:

The South Africa healthcare contract research outsourcing market is characterized by a mix of global contract research organizations (CROs), regional service providers, and academic research institutions, creating a competitive and dynamic landscape. Leading international CROs such as IQVIA, Parexel, and ICON Plc have established a strong presence in the country, leveraging their global expertise, advanced research technologies, and regulatory knowledge to attract major pharmaceutical and biotechnology clients. These companies benefit from well-established networks, extensive clinical trial experience, and access to a skilled workforce, allowing them to dominate the market. In September 2023, ICON partnered with the U.S. Biomedical Advanced Research and Development Authority (BARDA) to conduct clinical trials for advanced COVID-19 vaccines. Local CROs and research institutions play a vital role in catering to region-specific research needs, regulatory compliance, and cost-effective clinical trial services. Firms such as Africlin, TASK Applied Science, and Bioclinca South Africa have gained market share by offering specialized services, personalized client engagement, and localized expertise. As competition intensifies, differentiation through technological innovation, strategic partnerships, and regulatory efficiency will be key to gaining a competitive advantage in the market.

Recent Developments:

In February 2024, Charles River Laboratoriesentered into a strategic partnership with Pluristyx Inc. This collaboration aims to enhance research capabilities by providing access to advanced research tools that support the development of new therapeutics. This partnership is significant as it expands Charles River’s service offerings and strengthens its position in the competitive HCRO landscape, particularly in South Africa, which is becoming a key destination for clinical trials in sub-Saharan Africa due to its well-established infrastructure and diverse patient population.
in May 2023, Charles River Laboratoriesalso partnered with Wheeler Bio to launch RightSourceSM, a biologics testing laboratory. This facility is designed to provide quality control services for a broader range of companies, reflecting the increasing trend of outsourcing biologics testing and quality control services to specialized CROs.

Market Concentration & Characteristics:

The South Africa healthcare contract research outsourcing market exhibits a moderate to high market concentration, with a mix of global CROs, regional service providers, and specialized research institutions driving competition. Leading international CROs such as IQVIA, Parexel, and ICON Plc dominate a significant portion of the market, leveraging their global infrastructure, advanced clinical research technologies, and established client relationships. These firms benefit from economies of scale, regulatory expertise, and comprehensive service offerings, positioning them as preferred partners for large pharmaceutical and biotechnology companies. Regional and mid-sized CROs, including Africlin, TASK Applied Science, and Bioclinca South Africa, cater to niche research needs, local regulatory compliance, and cost-efficient clinical trial management. The market is characterized by increasing specialization, digital transformation, and a growing focus on decentralized trials. As demand for faster, cost-effective research solutions rises, competition is expected to intensify, with firms differentiating through technological innovation, patient recruitment efficiency, and regulatory agility.

Report Coverage:

The research report offers an in-depth analysis based on By Service, By Therapeutic Area and By End-user. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook:

Rising clinical trial activities driven by increasing cases of chronic and infectious diseases.
Growing adoption of decentralized trials with remote monitoring, AI-driven analytics, and digital health solutions.
Streamlined regulatory processes by SAHPRA reducing approval timelines and attracting global CROs.
Expansion of the biopharmaceutical sector, with increasing focus on biosimilars, gene therapies, and precision medicine.
Increasing foreign direct investment (FDI) from international pharmaceutical and biotech firms strengthening research infrastructure.
Emergence of new research hubs beyond Johannesburg, Cape Town, and Pretoria, improving patient diversity in trials.
Enhanced data security and compliance with stricter regulations and advanced cybersecurity measures.
Rising strategic collaborations among CROs, pharmaceutical companies, and academic research institutions.
Growing demand for cost-efficient research solutions leading to greater outsourcing of clinical trials.
Sustained market expansion driven by technological advancements, regulatory evolution, and increasing contract research demand.

CHAPTER NO. 1 : INTRODUCTION 19

1.1. Report Description 19

Purpose of the Report 19

USP & Key Offerings 19

1.2. Key Benefits for Stakeholders 19

1.3. Target Audience 20

1.4. Report Scope 20

CHAPTER NO. 2 : EXECUTIVE SUMMARY 21

2.1. South Africa Healthcare Contract Research Outsourcing Market Snapshot 21

2.2. South Africa Healthcare Contract Research Outsourcing Market, 2018 – 2032 (USD Million) 23

CHAPTER NO. 3 : SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET – INDUSTRY ANALYSIS 24

3.1. Introduction 24

3.2. Market Drivers 25

3.3. Increased Prevalence of Diseases 25

3.4. Growing Healthcare Infrastructure 26

3.5. Market Restraints 27

3.6. Limited Infrastructure and Resources 27

3.7. Market Opportunities 28

3.8. Market Opportunity Analysis 28

3.9. Porter’s Five Forces Analysis 29

CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE 30

4.1. Company Market Share Analysis – 2023 30

4.1.1. South Africa Healthcare Contract Research Outsourcing Market: Company Market Share, by Volume, 2023 30

4.1.2. South Africa Healthcare Contract Research Outsourcing Market: Company Market Share, by Revenue, 2023 31

4.1.3. South Africa Healthcare Contract Research Outsourcing Market: Top 6 Company Market Share, by Revenue, 2023 31

4.1.4. South Africa Healthcare Contract Research Outsourcing Market: Top 3 Company Market Share, by Revenue, 2023 32

4.2. South Africa Healthcare Contract Research Outsourcing Market Company Revenue Market Share, 2023 33

4.3. Company Assessment Metrics, 2023 34

4.3.1. Stars 34

4.3.2. Emerging Leaders 34

4.3.3. Pervasive Players 34

4.3.4. Participants 34

4.4. Start-ups /SMEs Assessment Metrics, 2023 34

4.4.1. Progressive Companies 34

4.4.2. Responsive Companies 34

4.4.3. Dynamic Companies 34

4.4.4. Starting Blocks 34

4.5. Strategic Developments 35

4.5.1. Acquisitions & Mergers 35

New Product Launch 35

Regional Expansion 35

4.6. Key Players Product Matrix 37

CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS 38

5.1. PESTEL 38

5.1.1. Political Factors 38

5.1.2. Economic Factors 38

5.1.3. Social Factors 38

5.1.4. Technological Factors 38

5.1.5. Environmental Factors 38

5.1.6. Legal Factors 38

5.2. Adjacent Market Analysis 38

CHAPTER NO. 6 : SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET – BY SERVICE SEGMENT ANALYSIS 39

6.1. South Africa Healthcare Contract Research Outsourcing Market Overview, by Service Segment 39

6.1.1. South Africa Healthcare Contract Research Outsourcing Market Revenue Share, By Service, 2023 & 2032 40

6.1.2. South Africa Healthcare Contract Research Outsourcing Market Attractiveness Analysis, By Service 41

6.1.3. Incremental Revenue Growth Opportunity, by Service, 2024 – 2032 41

6.1.4. South Africa Healthcare Contract Research Outsourcing Market Revenue, By Service, 2018, 2023, 2027 & 2032 42

6.2. Clinical Trial Services 43

6.3. Clinical Data Management & Biometrics 44

6.4. Pharmacovigilance 45

6.5. Regulatory Services 46

6.6. Medical Writing 47

6.7. Site Management Protocol 48

6.8. Others 49

CHAPTER NO. 7 : SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET – BY THERAPEUTIC AREA SEGMENT ANALYSIS 50

7.1. South Africa Healthcare Contract Research Outsourcing Market Overview, by Therapeutic Area Segment 50

7.1.1. South Africa Healthcare Contract Research Outsourcing Market Revenue Share, By Therapeutic Area, 2023 & 2032 51

7.1.2. South Africa Healthcare Contract Research Outsourcing Market Attractiveness Analysis, By Therapeutic Area 52

7.1.3. Incremental Revenue Growth Opportunity, by Therapeutic Area, 2024 – 2032 52

7.1.4. South Africa Healthcare Contract Research Outsourcing Market Revenue, By Therapeutic Area, 2018, 2023, 2027 & 2032 53

7.2. Oncology/Hematology 54

7.3. Respiratory 55

7.4. Central Nervous System (CNS) 56

7.5. Cardiovascular (CV)/Metabolic 57

7.6. Rare Diseases 58

7.7. Infectious Diseases 59

7.8. Immunology 60

7.9. Others 61

CHAPTER NO. 8 : SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET – BY END-USER SEGMENT ANALYSIS 62

8.1. South Africa Healthcare Contract Research Outsourcing Market Overview, by End-user Segment 62

8.1.1. South Africa Healthcare Contract Research Outsourcing Market Revenue Share, By End-user, 2023 & 2032 63

8.1.2. South Africa Healthcare Contract Research Outsourcing Market Attractiveness Analysis, By End-user 64

8.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 64

8.1.4. South Africa Healthcare Contract Research Outsourcing Market Revenue, By End-user, 2018, 2023, 2027 & 2032 65

8.2. Pharmaceutical and Biotech Companies 66

8.2.1. South Africa Pharmaceutical and Biotech Companies South Africa Healthcare Contract Research Outsourcing Market Revenue, By Region, 2018 – 2023 (USD Million) 67

8.2.2. South Africa Pharmaceutical and Biotech Companies South Africa Healthcare Contract Research Outsourcing Market Revenue, By Region, 2024 – 2032 (USD Million) 67

8.3. Medical Devices 68

8.4. Government Organizations 69

8.5. Academic Institutes 70

8.6. Others 71

CHAPTER NO. 9 : HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET – ANALYSIS 72

9.1.1. South Africa Healthcare Contract Research Outsourcing Market Revenue, By Service, 2018 – 2023 (USD Million) 72

9.1.2. South Africa Healthcare Contract Research Outsourcing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 73

9.1.3. South Africa Healthcare Contract Research Outsourcing Market Revenue, By End-user, 2018 – 2023 (USD Million) 74

CHAPTER NO. 10 : COMPANY PROFILES 75

10.1. Labcorp Drug Development 75

10.1.1. Company Overview 75

10.1.2. Product Portfolio 75

10.1.3. Swot Analysis 75

10.1.4. Business Strategy 76

10.1.5. Financial Overview 76

10.2. Medpace 77

10.3. IQVIA 77

10.4. Parexel International 77

10.5. Covance 77

10.6. Charles River Laboratories 77

10.7. PPD 77

10.8. Syneos Health 77

10.9. Thermo Fisher Scientific Inc. 77

10.10. Pharmalex 77

10.11. Avoca CRO 77

List of Figures

FIG NO. 1. South Africa Healthcare Contract Research Outsourcing Market Revenue, 2018 – 2032 (USD Million) 23

FIG NO. 2. Porter’s Five Forces Analysis for South Africa Healthcare Contract Research Outsourcing Market 29

FIG NO. 3. Company Share Analysis, 2023 30

FIG NO. 4. Company Share Analysis, 2023 31

FIG NO. 5. Company Share Analysis, 2023 31

FIG NO. 6. Company Share Analysis, 2023 32

FIG NO. 7. South Africa Healthcare Contract Research Outsourcing Market – Company Revenue Market Share, 2023 33

FIG NO. 8. South Africa Healthcare Contract Research Outsourcing Market Revenue Share, By Service, 2023 & 2032 40

FIG NO. 9. Market Attractiveness Analysis, By Service 41

FIG NO. 10. Incremental Revenue Growth Opportunity by Service, 2024 – 2032 41

FIG NO. 11. South Africa Healthcare Contract Research Outsourcing Market Revenue, By Service, 2018, 2023, 2027 & 2032 42

FIG NO. 12. South Africa Healthcare Contract Research Outsourcing Market for Clinical Trial Services, Revenue (USD Million) 2018 – 2032 43

FIG NO. 13. South Africa Healthcare Contract Research Outsourcing Market for Clinical Data Management & Biometrics, Revenue (USD Million) 2018 – 2032 44

FIG NO. 14. South Africa Healthcare Contract Research Outsourcing Market for Pharmacovigilance, Revenue (USD Million) 2018 – 2032 45

FIG NO. 15. South Africa Healthcare Contract Research Outsourcing Market for Regulatory Services, Revenue (USD Million) 2018 – 2032 46

FIG NO. 16. South Africa Healthcare Contract Research Outsourcing Market for Medical Writing, Revenue (USD Million) 2018 – 2032 47

FIG NO. 17. South Africa Healthcare Contract Research Outsourcing Market for Site Management Protocol, Revenue (USD Million) 2018 – 2032 48

FIG NO. 18. South Africa Healthcare Contract Research Outsourcing Market for Others, Revenue (USD Million) 2018 – 2032 49

FIG NO. 19. South Africa Healthcare Contract Research Outsourcing Market Revenue Share, By Therapeutic Area, 2023 & 2032 51

FIG NO. 20. Market Attractiveness Analysis, By Therapeutic Area 52

FIG NO. 21. Incremental Revenue Growth Opportunity by Therapeutic Area, 2024 – 2032 52

FIG NO. 22. South Africa Healthcare Contract Research Outsourcing Market Revenue, By Therapeutic Area, 2018, 2023, 2027 & 2032 53

FIG NO. 23. South Africa Healthcare Contract Research Outsourcing Market for Oncology/Hematology, Revenue (USD Million) 2018 – 2032 54

FIG NO. 24. South Africa Healthcare Contract Research Outsourcing Market for Respiratory, Revenue (USD Million) 2018 – 2032 55

FIG NO. 25. South Africa Healthcare Contract Research Outsourcing Market for Central Nervous System (CNS), Revenue (USD Million) 2018 – 2032 56

FIG NO. 26. South Africa Healthcare Contract Research Outsourcing Market for Cardiovascular (CV)/Metabolic, Revenue (USD Million) 2018 – 2032 57

FIG NO. 27. South Africa Healthcare Contract Research Outsourcing Market for Rare Diseases, Revenue (USD Million) 2018 – 2032 58

FIG NO. 28. South Africa Healthcare Contract Research Outsourcing Market for Infectious Diseases, Revenue (USD Million) 2018 – 2032 59

FIG NO. 29. South Africa Healthcare Contract Research Outsourcing Market for Immunology, Revenue (USD Million) 2018 – 2032 60

FIG NO. 30. South Africa Healthcare Contract Research Outsourcing Market for Others, Revenue (USD Million) 2018 – 2032 61

FIG NO. 31. South Africa Healthcare Contract Research Outsourcing Market Revenue Share, By End-user, 2023 & 2032 63

FIG NO. 32. Market Attractiveness Analysis, By End-user 64

FIG NO. 33. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 64

FIG NO. 34. South Africa Healthcare Contract Research Outsourcing Market Revenue, By End-user, 2018, 2023, 2027 & 2032 65

FIG NO. 35. South Africa Healthcare Contract Research Outsourcing Market for Pharmaceutical and Biotech Companies, Revenue (USD Million) 2018 – 2032 66

FIG NO. 36. South Africa Healthcare Contract Research Outsourcing Market for Medical Devices, Revenue (USD Million) 2018 – 2032 68

FIG NO. 37. South Africa Healthcare Contract Research Outsourcing Market for Government Organizations, Revenue (USD Million) 2018 – 2032 69

FIG NO. 38. South Africa Healthcare Contract Research Outsourcing Market for Academic Institutes, Revenue (USD Million) 2018 – 2032 70

FIG NO. 39. South Africa Healthcare Contract Research Outsourcing Market for Others, Revenue (USD Million) 2018 – 2032 71

List of Tables

TABLE NO. 1. : South Africa Healthcare Contract Research Outsourcing Market: Snapshot 21

TABLE NO. 2. : Drivers for the South Africa Healthcare Contract Research Outsourcing Market: Impact Analysis 25

TABLE NO. 3. : Restraints for the South Africa Healthcare Contract Research Outsourcing Market: Impact Analysis 27

TABLE NO. 4. : South Africa Pharmaceutical and Biotech Companies South Africa Healthcare Contract Research Outsourcing Market Revenue, By Region, 2018 – 2023 (USD Million) 67

TABLE NO. 5. : South Africa Pharmaceutical and Biotech Companies South Africa Healthcare Contract Research Outsourcing Market Revenue, By Region, 2024 – 2032 (USD Million) 67

TABLE NO. 6. : South Africa Healthcare Contract Research Outsourcing Market Revenue, By Service, 2018 – 2023 (USD Million) 72

TABLE NO. 7. : South Africa Healthcare Contract Research Outsourcing Market Revenue, By Service, 2024 – 2032 (USD Million) 72

TABLE NO. 8. : South Africa Healthcare Contract Research Outsourcing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 73

TABLE NO. 9. : South Africa Healthcare Contract Research Outsourcing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 73

TABLE NO. 10. : South Africa Healthcare Contract Research Outsourcing Market Revenue, By End-user, 2018 – 2023 (USD Million) 74

TABLE NO. 11. : South Africa Healthcare Contract Research Outsourcing Market Revenue, By End-user, 2024 – 2032 (USD Million) 74

Frequently Asked Questions

What is the current size of the South Africa Healthcare Contract Research Outsourcing Market?

The market is valued at USD 670.72 million in 2024 and is projected to grow to USD 1,076.12 million by 2032, with a CAGR of 6.09% from 2024 to 2032.

What factors are driving the growth of the South Africa Healthcare Contract Research Outsourcing Market?

Growth is driven by the rising prevalence of chronic diseases, increasing demand for cost-effective clinical research, regulatory alignment with international standards, and the expansion of biopharmaceutical research in South Africa.

Who are the major players in the South Africa Healthcare Contract Research Outsourcing Market?

Leading players include global CROs such as IQVIA, Parexel, and ICON Plc, alongside regional providers like Africlin, TASK Applied Science, and Bioclinca South Africa.

Which regions dominate the South Africa Healthcare Contract Research Outsourcing Market?

Johannesburg, Cape Town, and Pretoria lead the market, accounting for the majority share due to their advanced medical infrastructure, research facilities, and skilled workforce.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Let us help you

MIKE, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –